Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"12,205 (6,149, 20,052)","80.0% (64.9%, 99.3%)","71.1% (58.0%, 84.0%)","16.4% (12.0%, 26.8%)","77.4% (62.1%, 99.0%)","20.0 (16.2, 24.8)","17.8 (14.5, 21.0)","4.1 (3.0, 6.7)","19.4 (15.5, 24.8)",,,,,
"(p=None, None), q=(None, None), c=0.500)","9,979 (6,584, 16,274)","87.8% (73.4%, 99.8%)","60.4% (41.6%, 79.7%)","12.4% (8.4%, 15.7%)","85.5% (70.1%, 99.8%)","21.9 (18.4, 25.0)","15.1 (10.4, 19.9)","3.1 (2.1, 3.9)","21.4 (17.5, 24.9)","-15.6% (-35.9%, 7.4%)","10.2% (0.5%, 19.4%)","-15.5% (-33.8%, -2.2%)","-21.9% (-47.4%, -5.8%)","11.1% (0.7%, 19.9%)"
"(p=None, None), q=(None, None), c=0.750)","10,325 (6,794, 18,003)","87.9% (72.6%, 99.8%)","59.2% (40.9%, 78.7%)","11.9% (7.6%, 15.0%)","85.9% (69.5%, 99.7%)","22.0 (18.2, 24.9)","14.8 (10.2, 19.7)","3.0 (1.9, 3.8)","21.5 (17.4, 24.9)","-13.3% (-35.7%, 11.5%)","10.4% (0.5%, 20.0%)","-17.2% (-36.3%, -4.2%)","-25.5% (-49.7%, -8.6%)","11.4% (0.6%, 20.9%)"
"(p=None, None), q=(None, None), c=1.000)","10,331 (6,870, 16,790)","88.6% (74.5%, 99.8%)","58.7% (39.8%, 78.3%)","11.4% (7.5%, 14.7%)","86.5% (71.4%, 99.8%)","22.1 (18.6, 25.0)","14.7 (9.9, 19.6)","2.8 (1.9, 3.7)","21.6 (17.8, 24.9)","-12.2% (-35.5%, 16.2%)","11.3% (0.5%, 21.3%)","-18.0% (-37.4%, -4.0%)","-28.5% (-52.3%, -9.3%)","12.4% (0.7%, 22.4%)"
